
Sign up to save your podcasts
Or


At the beginning of the pandemic, Daniel Batlle, MD, professor of medicine in the Division of Nephrology-Hypertension at Northwestern, proposed a hypothesis that soluble ACE2 could treat the SARS-CoV-2 virus and lead to full recovery and survival. Now, he has exciting preliminary results to share.
By Northwestern University Feinberg School of Medicine4.9
2424 ratings
At the beginning of the pandemic, Daniel Batlle, MD, professor of medicine in the Division of Nephrology-Hypertension at Northwestern, proposed a hypothesis that soluble ACE2 could treat the SARS-CoV-2 virus and lead to full recovery and survival. Now, he has exciting preliminary results to share.

91,127 Listeners

21,911 Listeners

43,555 Listeners

91 Listeners

6,470 Listeners

113,179 Listeners

5 Listeners

56,962 Listeners

0 Listeners

10,334 Listeners

33 Listeners

3,051 Listeners

8,222 Listeners

29,364 Listeners

1,589 Listeners

4,342 Listeners

7 Listeners

630 Listeners

14,064 Listeners